Can Abilify Worsen Anxiety?
Yes, Abilify (aripiprazole) can worsen anxiety in some patients, particularly during treatment initiation or when combined with other medications like lamotrigine and antidepressants. This is a recognized adverse effect documented in FDA labeling and clinical studies.
Evidence from FDA Drug Labeling
The FDA label explicitly lists anxiety and restlessness as common side effects of aripiprazole 1. In adult clinical trials:
- Anxiety occurred in 17% of patients on Abilify versus 13% on placebo
- Restlessness occurred in 5% of patients on Abilify versus 3% on placebo
- Akathisia (inner sense of restlessness/need to move) occurred in 13% of patients on Abilify versus 4% on placebo 1
The FDA label also warns about insomnia (18% vs 13% placebo) and agitation (19% vs 17% placebo), which can manifest as or worsen anxiety symptoms 1.
Clinical Context and Mechanism
The anxiety-worsening effect appears related to aripiprazole's unique mechanism as a dopamine partial agonist. When patients have been on traditional dopamine-blocking antipsychotics long-term, their postsynaptic dopamine receptors may be upregulated. Switching to aripiprazole can increase dopaminergic activity, potentially worsening dopamine-associated symptoms including agitation, anxiety, and paranoia 2.
High-Risk Scenarios
Patients at greatest risk for anxiety worsening include:
Those with pre-existing anxious depression: Patients with baseline anxiety (GAD-7 ≥10) showed significantly higher rates of nervousness and agitation when starting aripiprazole, particularly in the first 2 weeks of treatment 3
Combination therapy with lamotrigine and antidepressants: Case reports document severe akathisia, anxiety, and even suicidal ideation when aripiprazole is combined with lamotrigine and antidepressants in mood disorder patients 4
Patients switching from long-term dopamine antagonists: Those with extended histories of traditional antipsychotic use may experience increased agitation and anxiety when converted to aripiprazole 2
Clinical Management Algorithm
If initiating aripiprazole:
- Start with low doses (2-5 mg) in patients with mood disorders or baseline anxiety 4
- Monitor closely during the first 2 weeks when anxiety symptoms are most likely to emerge 3
- Watch specifically for akathisia, which can manifest as or worsen anxiety 1, 4
If anxiety worsens after starting aripiprazole:
- Consider dose reduction as first-line management 5
- Add adjunctive propranolol (10-30 mg, 2-3 times daily) to manage akathisia-related anxiety 5
- If symptoms are severe or include suicidal ideation, discontinue aripiprazole immediately 4
- Consider switching to quetiapine or olanzapine if an antipsychotic is still needed 5
Important Caveats
While anxiety is a recognized side effect, the 2022 systematic review found that aripiprazole can actually reduce anxiety symptoms in some patients with borderline personality disorder 6. Additionally, a 2026 review noted that aripiprazole has shown benefit for anxiety symptoms in patients with MDD and comorbid anxiety 7. This paradoxical effect means the drug's impact on anxiety is patient-specific and context-dependent.
The key distinction is that aripiprazole may worsen anxiety as an adverse effect (particularly akathisia-related) while potentially improving anxiety as a therapeutic effect in certain psychiatric conditions. Close monitoring during initiation is essential to distinguish between these outcomes.